glp 1 based therapeutics summit GLP-1-Based GLP-1-Based Therapeutics Summit | Conference

Online Journal | Justin Plank | January 2025 Background Every year, the United States spends an estimated $173 billion treating obesity-related diseases like diabetes and heart disease, more than the annual budgets of 42 U.S

Covers SURPASS/SURMOUNT trials, dosing, and semaglutide comparison.

or Canada) take on more consumer behaviors for their health and wellbeing, they are seeking care across sites beyond clinics and doctors offices notably online via telehealth and ecommerce channels as well as retail health environments like medi-spas or nutrition shops

Do not exceed recommended serving

This document summarizes information about GLP-1 receptor agonists for treating diabetes

The Appetite Revolution Theres a slightly awkward conversation happening in the health world right now